| Tulio Alberto Valdez, MD | |
|
725 Welch Rd, Palo Alto, CA 94304-1601 | |
| (650) 497-8000 | |
| Not Available |
| Full Name | Tulio Alberto Valdez |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology - Pediatric Otolaryngology |
| Location | 725 Welch Rd, Palo Alto, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235351099 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YP0228X | Otolaryngology - Pediatric Otolaryngology | C149490 (California) | Primary |
| 207Y00000X | Otolaryngology | C149490 (California) | Secondary |
| Entity Name | Stanford Health Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437292927 PECOS PAC ID: 6709797491 Enrollment ID: O20031124000348 |
News Archive
Silence Therapeutics plc announces the issuance of United States patent 7,772,203, titled "Methods and Compositions for Controlling Efficacy of RNA Silencing," by the United States Patent and Trademark Office (USPTO). The issued patent generally claims methods of enhancing RNA silencing with a double stranded RNA interference (RNAi) agent. The patent's RNA silencing method claims include coverage for the administering of a pharmaceutical composition containing short interfering RNA (siRNA), micro RNA (miRNA), pre-miRNA or short hairpin (shRNA) molecules. Silence believes the proprietary structural modification techniques covered in this patent will play a key role in increasing the potential therapeutic efficacy of RNAi therapeutics.
Using inexpensive air filters may help reduce cardiovascular disease risk that results from exposure to air pollution, according to researchers from Canada, who studied healthy adultsliving in a small community in British Columbia where wood burning stoves are the main sources of pollution.
Immune Pharmaceuticals, Inc. announced today that its Chief Executive Officer, Dr. Daniel Teper, has established a stock trading plan with respect to the purchases of up to an aggregate of $250,000 of shares of Immune common stock in accordance with Rule 10b5-1 under the Exchange Act and other applicable federal securities laws and regulations adopted by the Securities and Exchange Commission.
Sleep apnea is a very common sleep disorder characterised by breathing pauses and periodic snoring. According to some studies, as much as ten percent of the population suffer from it, but up to nine out of ten cases remain undiagnosed because symptoms are sometimes mild and there are a lack of resources in diagnostics.
› Verified 4 days ago
| Entity Name | Lpch Medical Group Div Of Lucile |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417907940 PECOS PAC ID: 0840298543 Enrollment ID: O20061113000232 |
News Archive
Silence Therapeutics plc announces the issuance of United States patent 7,772,203, titled "Methods and Compositions for Controlling Efficacy of RNA Silencing," by the United States Patent and Trademark Office (USPTO). The issued patent generally claims methods of enhancing RNA silencing with a double stranded RNA interference (RNAi) agent. The patent's RNA silencing method claims include coverage for the administering of a pharmaceutical composition containing short interfering RNA (siRNA), micro RNA (miRNA), pre-miRNA or short hairpin (shRNA) molecules. Silence believes the proprietary structural modification techniques covered in this patent will play a key role in increasing the potential therapeutic efficacy of RNAi therapeutics.
Using inexpensive air filters may help reduce cardiovascular disease risk that results from exposure to air pollution, according to researchers from Canada, who studied healthy adultsliving in a small community in British Columbia where wood burning stoves are the main sources of pollution.
Immune Pharmaceuticals, Inc. announced today that its Chief Executive Officer, Dr. Daniel Teper, has established a stock trading plan with respect to the purchases of up to an aggregate of $250,000 of shares of Immune common stock in accordance with Rule 10b5-1 under the Exchange Act and other applicable federal securities laws and regulations adopted by the Securities and Exchange Commission.
Sleep apnea is a very common sleep disorder characterised by breathing pauses and periodic snoring. According to some studies, as much as ten percent of the population suffer from it, but up to nine out of ten cases remain undiagnosed because symptoms are sometimes mild and there are a lack of resources in diagnostics.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tulio Alberto Valdez, MD 725 Welch Rd, Palo Alto, CA 94304-1601 Ph: (650) 497-8000 | Tulio Alberto Valdez, MD 725 Welch Rd, Palo Alto, CA 94304-1601 Ph: (650) 497-8000 |
News Archive
Silence Therapeutics plc announces the issuance of United States patent 7,772,203, titled "Methods and Compositions for Controlling Efficacy of RNA Silencing," by the United States Patent and Trademark Office (USPTO). The issued patent generally claims methods of enhancing RNA silencing with a double stranded RNA interference (RNAi) agent. The patent's RNA silencing method claims include coverage for the administering of a pharmaceutical composition containing short interfering RNA (siRNA), micro RNA (miRNA), pre-miRNA or short hairpin (shRNA) molecules. Silence believes the proprietary structural modification techniques covered in this patent will play a key role in increasing the potential therapeutic efficacy of RNAi therapeutics.
Using inexpensive air filters may help reduce cardiovascular disease risk that results from exposure to air pollution, according to researchers from Canada, who studied healthy adultsliving in a small community in British Columbia where wood burning stoves are the main sources of pollution.
Immune Pharmaceuticals, Inc. announced today that its Chief Executive Officer, Dr. Daniel Teper, has established a stock trading plan with respect to the purchases of up to an aggregate of $250,000 of shares of Immune common stock in accordance with Rule 10b5-1 under the Exchange Act and other applicable federal securities laws and regulations adopted by the Securities and Exchange Commission.
Sleep apnea is a very common sleep disorder characterised by breathing pauses and periodic snoring. According to some studies, as much as ten percent of the population suffer from it, but up to nine out of ten cases remain undiagnosed because symptoms are sometimes mild and there are a lack of resources in diagnostics.
› Verified 4 days ago
Shannon Wu, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 801 Welch Rd, Palo Alto, CA 94304 Phone: 650-723-5281 | |
Michael Mccaffrey, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 795 El Camino Real, Palo Alto, CA 94301 Phone: 650-321-4121 | |
Dr. Dong Kyoo Richard Kang, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 | |
Brittany Leader, Otolaryngology Medicare: Medicare Enrolled Practice Location: 101 Addison Ave, Palo Alto, CA 94301 Phone: 650-433-8621 Fax: 650-434-0061 | |
Dylan Kar-shuen Chan, M.D., PH.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 801 Welch Rd, Palo Alto, CA 94304 Phone: 650-723-6661 | |
Seth Joseph Davis, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Palo Alto, CA 94304 Phone: 650-723-4000 |